Geode Capital Management, LLC Surrozen, Inc. Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.44 - $0.89 $87 - $176
198 Added 0.12%
172,148 $84,000
Q4 2022

Feb 13, 2023
SELL
$0.42 - $2.01 $176 - $844
-420 Reduced 0.24%
171,950 $100,000
Q1 2022

May 13, 2022
BUY
$2.2 - $6.01 $34,432 - $94,062
15,651 Added 9.99%
172,370 $518,000
Q4 2021

Feb 11, 2022
BUY
$6.0 - $9.92 $169,080 - $279,545
28,180 Added 21.92%
156,719 $1.01 Million
Q3 2021

Nov 12, 2021
BUY
$6.98 - $12.03 $897,202 - $1.55 Million
128,539 New
128,539 $910,000

Others Institutions Holding SRZN

# of Institutions
3
Shares Held
4.52M
Call Options Held
0
Put Options Held
0
View Full List

About Surrozen, Inc.

SRZN Quotes by TradingView
  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $342M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email